-transparent.png){kind=logo}
To reduce the nephrotoxicity of cis-dichlorodiammineplatinum (cis-DDP) we have used tetrahydroindazolonedicarboxylic acid (HIDA) in doses of 200, 100 or 50 mg/kg 4, 2 and 1 h before or 1, 2 and 4 h after cis-DDP treatment (10 mg/kg). At any dose, given 2 or 1 h before or 1 h after cis-DDP, HIDA reduced the kidney damage as judged by the blood urea nitrogen (BUN) levels in blood. No protective effect was seen when HIDA was given 4 h before cis-DDP injection. Studies in vitro on L1210 cells have revealed that HIDA does not directly interact with cis-DDP.
Related Publications
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
January 1979,
Cancer treatment reports,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
May 1979,
Cancer treatment reports,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
November 1990,
Cancer research,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
May 1984,
Research communications in chemical pathology and pharmacology,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
January 1979,
Voprosy onkologii,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
January 1982,
Oncology,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
April 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
October 1984,
European journal of cancer & clinical oncology,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
January 1980,
Cancer treatment reports,
M Radacić, and
M Boranić, and
D Skarić, and
V Skarić, and
H Mihalić, and
V Gajsak, and
J Jercić, and
P Lelieveld
January 1979,
Cancer treatment reports,
